Glaxo Smith Kline Buildings, London

Glaxo Smith Kline Buildings, GSK London, Photo, News, Design, Property, Image

Glaxo Smith Kline London

GSK Building Development in Brentford, west London, England, UK

4 Jul 2009

Glaxo Smith Kline Building

Location: opposite the Great West House, West of Boston Manor Rd and North of the Great West Rd

Glaxo Smith Kline Building London Glaxo Smith Kline London Glaxo Smith Kline Building Glaxo Smith Kline Building London
photos © Nick Weall

GlaxoSmithKline Global Headquarters, Brentford

Design: RMJM Hillier, architects

Address: 980 Great West Rd, Brentford, Middlesex TW8 9GS, UK

Phone: 020 8047 5000

GlaxoSmithKline HQ
image from architects

A 1,000,000 sf gateway tower and landmark building that achieves ambitious
environmental goals and supports the collaborative culture of the company.

GlaxoSmithKline London

GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in Brentford, London. As of March 2014, it was the world’s sixth-largest pharmaceutical company after Johnson & Johnson, Novartis, Hoffmann-La Roche, Pfizer, and Sanofi, measured by 2013 revenue. The company was established in 2000 by the merger of Glaxo Wellcome (formed from the acquisition of Wellcome plc by Glaxo plc) and SmithKline Beecham plc (formed from the merger of Beecham plc and SmithKline Beckman Corporation, which in turn was formed by combining the Smith Kline French and Beckman companies).

The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. As of 2 May 2014 it had a market capitalisation of £79 billion, the fourth-largest of any company listed on the London Stock Exchange. It has a secondary listing on the New York Stock Exchange. Andrew Witty has been the chief executive officer since May 2008.

GSK manufactures drugs and vaccines for major disease areas such as asthma, cancer, infections, diabetes, digestive and mental health conditions, the biggest selling of which were Advair, Avodart, Flovent, Augmentin, Lovaza, and Lamictal in 2013. Many medicines were historically discovered or developed at GSK and its legacy companies and are now sold as generics. Its drugs and vaccines earned £21.3 million in 2013. Its consumer healthcare division, which earned £5.2 million in 2013, sells oral healthcare and nutritional products, drinks and over-the-counter medicines, including Sensodyne, Boost and Horlicks.
Source: wikipedia

Location:Boston Manor Road, London, UK